Compare ARTW & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARTW | HKPD |
|---|---|---|
| Founded | 1956 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 10.6M |
| IPO Year | N/A | 2025 |
| Metric | ARTW | HKPD |
|---|---|---|
| Price | $2.36 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 47.4K | ★ 50.7K |
| Earning Date | 02-04-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $22,975,408.00 | $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.75 | ★ N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $1.43 | $0.66 |
| 52 Week High | $4.71 | $2.76 |
| Indicator | ARTW | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 39.32 | 50.83 |
| Support Level | $2.11 | $0.75 |
| Resistance Level | $2.44 | $0.89 |
| Average True Range (ATR) | 0.20 | 0.07 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 13.83 | 65.82 |
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.